Clinical Trial Update: Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN）

View source ↗

Summary

Clinical trial update indicating the status of a study evaluating eflornithine after immunotherapy for high-risk neuroblastoma; the trial is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Eflornithine (eflornithine)

Snippet

Sponsor: Shanghai Children's Hospital | Conditions: High Risk Neuroblastoma | Status: ACTIVE_NOT_RECRUITING